Trials / Completed
CompletedNCT04639804
Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male Volunteers
An Open-label, Randomized, Crossover Study to Evaluate the Pharmacokinetic Interaction Between Tegoprazan and Non-steroidal Anti-inflammatory Drugs (NSAIDs) After Multiple Oral Dosing in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- HK inno.N Corporation · Industry
- Sex
- Male
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study aims to evaluate the pharmacokinetic (PK) interaction between tegoprazan and non-steroidal anti-inflammatory drugs (NSAIDs) after given each alone and in their combination in healthy male adults.
Detailed description
A randomized, open-label, multiple-dose, 6-sequence-arm, 3-period cross-over study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tegoprazan | Tegoprazan 50 mg tablet |
| DRUG | Naproxen | Naproxen 500 mg tablet |
| DRUG | Aceclofenac | Aceclofenac 100 mg tablet |
| DRUG | Celecoxib | Celecoxib 200 mg capsule |
Timeline
- Start date
- 2020-06-06
- Primary completion
- 2020-07-26
- Completion
- 2020-07-29
- First posted
- 2020-11-23
- Last updated
- 2020-11-23
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04639804. Inclusion in this directory is not an endorsement.